Calyxt
600 County Road D W.
Suite 8
New Brighton
Minnesota
55112
United States
About Calyxt
Calyxt, Inc. is a fast-growing, consumer-oriented ag company that utilizes its innovative, patented TALEN® technology to usher in a new era of agriculture and develop crop products with healthier characteristics for consumers – all the while helping farmers and food and agriculture industries reduce their environmental footprints in the context of climate change. Calyxt believes that agricultural technologies can have a profound, positive impact on humanity and is looking to engage those who share this passion for food and agriculture. Calyxt is located in Minneapolis-St. Paul, Minn., and is a wholly owned subsidiary of Cellectis.
93 articles about Calyxt
-
Calyxt to Present at the H.C Wainwright 23rd Annual Global Investment Conference
9/7/2021
Calyxt, Inc. today announced that a presentation given by management at the H.C Wainwright 23rd Annual Global Investment Conference will be available for viewing online on September 13th at 7:00 a.m. ET . The conference will be held in a virtual meeting format.
-
Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021
8/4/2021
Calyxt, Inc. today announced that management will present at the Canaccord Genuity 41st Annual Growth Conference at 11:00 a.m. ET .
-
Calyxt Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - July 27, 2021
7/27/2021
Calyxt, Inc., a plant-based biotechnology platform company, announced that, in accordance with the offer letter entered into on July 15, 2021, it has granted, effective July 27, 2021, an inducement award to Michael A. Carr, Calyxt's newly appointed President and Chief Executive Officer.
-
Calyxt Appoints Michael A. Carr as Chief Executive Officer
7/15/2021
Calyxt, Inc. (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced the appointment of Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021.
-
Calyx Releases RIM 7.0 to Optimize Regulatory Efficiencies
5/6/2021
Calyx, the eClinical and Regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, announced the availability of Calyx RIM v7.0 for its industry-leading Regulatory Information Management system.
-
Calyxt Successfully Transforms Hemp Genome
4/29/2021
New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pending Transformation Process is Calyxt's First Announced Innovation in a Broad Hemp Improvement Pipeline
-
Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services
1/11/2021
Calyx, a leading provider of Medical Imaging, eClinical, and Regulatory solutions and services to solve complex challenges in clinical research, launched as an independent company following the strategic separation of the Parexel Informatics business from Parexel International.
-
Calyxt Announces Collaboration with NRGene® to Advance its Product Pipeline
11/11/2020
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene® that includes the adoption of NRGene’s cloud-based genomics platform to support key Calyxt’s research projects.
-
Calyxt Announces Commercial Agreement with S&W Seed Company to Deliver Improved Quality Alfalfa
10/29/2020
Agreement has the Potential to Generate More Than $10 Million of License Revenue from U.S. Sales
-
Calyxt to Host Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern Time
10/27/2020
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will host a Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern time. The Virtual Analyst Day will be broadcasted via webcast, and include a review of the company’s research and development pipeline and a business update from management, followed by a Q&A session with the sell-side analyst community. Agenda: Date:
-
Calyxt Announces $15 Million Registered Direct Offering - Oct 16, 2020
10/16/2020
Calyxt, Inc., a plant-based technology company, announced that it has entered into definitive agreements with institutional investors for the purchase and sale of 3,750,000 shares of the Company’s common stock, at a purchase price of $4.00 per share, in a registered direct offering.
-
Calyxt Announces $15 Million Registered Direct Offering
10/16/2020
Cellectis S.A. announced that its majority-owned subsidiary Calyxt, Inc., a plant-based technology company, has entered into definitive agreements with institutional investors for the purchase and sale of 3,750,000 shares of Calyxt’s common stock, at a purchase price of $4.00 per share, in a registered direct offering.
-
Calyxt Appoints Sarah Reiter as Vice President of Business Development
10/14/2020
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has appointed Sarah Reiter as Vice President, Business Development. In this role, Ms. Reiter will drive new business opportunities at Calyxt to support the company’s recently announced go-to-market strategies.
-
Calyxt to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time
10/13/2020
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, November 5, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2020. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome and Chief Financial Officer Bill Koschak will host the conference call, followed by
-
Calyxt to Present at Upcoming September Investor Conferences
8/25/2020
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will participate in the following investor conferences during the month of September 2020: the LD 500 Virtual Investor Conference on September 1-4, 2020, and the H.C. Wainwright 22 nd Annual Global Investment Conference on September 14-16, 2020. Calyxt Chief Executive Officer Jim Blome and
-
Calyxt to Present at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020
8/3/2020
Calyxt to Present at the Canaccord Genuity 40 th Annual Growth Conference on Thursday, August 13, 2020
-
Calyxt to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020 at 8:00 a.m. Eastern Time
7/20/2020
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, August 6, 2020 at 8:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2020. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome, Chief Financial Officer Bill Koschak, Chief Science Officer Dan Voytas, Ph.D. and Chief
-
Calyxt’s High Oleic Low Linolenic Soybean Oil Deemed Non-Regulated by USDA
6/3/2020
Calyxt, Inc. announced that its high oleic low linolenic soybean has been deemed a non-regulated article under the “Am I Regulated?” process by Biotechnology Regulatory Services of the Animal and Plant Health Inspection Service, an agency of the United States Department of Agriculture.
-
Calyxt Launches New Website Showcasing the Power and Possibilities of Plants
3/24/2020
Improved Navigation and Functionality Supports Increased Virtual Connectivity with Customers, Collaborators and Growers
-
Calyxt to Host Third Quarter 2019 Results Conference Call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern Time
10/30/2019
Calyxt, Inc., a plant-based breeding and technology platform company, will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2019.